<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03894072</url>
  </required_header>
  <id_info>
    <org_study_id>Si066/2019</org_study_id>
    <nct_id>NCT03894072</nct_id>
  </id_info>
  <brief_title>HFHO vs CPAP During Thoracic Surgery</brief_title>
  <official_title>Effect of High Flow Humidified Oxygen on Non-ventilated Lung During Thoracic Surgery: a Cross-over Study Compared With Conventional CPAP (Continuous Positive Airway Pressure)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A single institutional cross-over study design to compare between high flow humidified oxygen&#xD;
      (HFHO) device versus conventional CPAP for non-ventilated lung during thoracic surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators hypothesize that HFHO may be an alternative tool to supply oxygen to&#xD;
      non-ventilated lung during one lung ventilation. CPAP can improve oxygenation at a cost of&#xD;
      lung hyperinflation which is an unwanted condition during thoracic surgery especially the&#xD;
      video-assisted one.&#xD;
&#xD;
      Recruiting adult patients who undergo lung surgeries that requires one-lung ventilation.&#xD;
      Exclusion criteria include the followings:-&#xD;
&#xD;
        1. Emergency case.&#xD;
&#xD;
        2. Patients with severe COPD(Chronic Obstructive Pulmonary Diseases).&#xD;
&#xD;
        3. Patients with moderate baseline hypoxemia (SpO2 &lt; 90% on room air).&#xD;
&#xD;
        4. Patients with severe hemoptysis.&#xD;
&#xD;
        5. Patients with upper or lower airway abnormalities.&#xD;
&#xD;
        6. Patients undergo pulmonary lavage.&#xD;
&#xD;
        7. Patients with known pulmonary hypertension.&#xD;
&#xD;
        8. Patients with known pulmonary/tracheobronchial infections.&#xD;
&#xD;
        9. Patients with suspected difficult airway.&#xD;
&#xD;
       10. Patients with BMI over 35.&#xD;
&#xD;
       11. Pregnant patients.&#xD;
&#xD;
      Following a standard anesthetic practice. All participants will receive an intravenous based&#xD;
      anesthetic with or without regional blocks. The appropriate sized double lumen endobronchial&#xD;
      tube will be placed and fiberoptic bronchoscope is used to verify a proper position. Patient&#xD;
      will also get an arterial line for frequent ABG (Arterial Blood Gases) samplings.&#xD;
&#xD;
      Computer generated randomization will divide patients into 2 groups. Baseline ABG will be&#xD;
      drawn. After one lung ventilation commenced for 20 minutes, the 2nd ABG will be drawn, the&#xD;
      surgeon who was blinded to the intervention will evaluate the quality of lung collapse using&#xD;
      5-point Likert scale. Then, patients will either receive a CPAP or HFHO (depends on&#xD;
      randomization) for 20 minutes. Up on 1st intervention completion, the 3rd ABG and lung&#xD;
      collapse evaluation will be performed.&#xD;
&#xD;
      Following the first intervention, the non-ventilated lung will be suctioned out and wait for&#xD;
      20 minutes. Another ABG will be sampled at this point.&#xD;
&#xD;
      The patient will receive the 2nd alternative intervention (CPAP or HFHO- depend on their&#xD;
      randomization) for 20 minutes. The final ABG and lung collapse evaluation will be performed.&#xD;
&#xD;
      If any severe hypoxemia/ hypercarbia and marked violation of protocol occurs. Patients will&#xD;
      be excluded.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Actual">November 30, 2019</completion_date>
  <primary_completion_date type="Actual">November 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>HFHO-CPAP CPAP-HFHO</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with improved oxygenation.</measure>
    <time_frame>20 minutes</time_frame>
    <description>Improvement of gas exchanges by arterial blood gases</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of lung collapsed.</measure>
    <time_frame>20 minutes</time_frame>
    <description>Lung collapse quality by surgeon using 5-point Likert scale where 5 = very good, 4= good, 3 = acceptable, 2 = poor and 1= very poor</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Hypoxaemia During Surgery</condition>
  <condition>Lung Hyperinflation</condition>
  <arm_group>
    <arm_group_label>HFHO-CPAP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will have HFHO before CPAP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CPAP-HFHO</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will have CPAP and then HFHO</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPAP</intervention_name>
    <description>Conventional CPAP</description>
    <arm_group_label>CPAP-HFHO</arm_group_label>
    <arm_group_label>HFHO-CPAP</arm_group_label>
    <other_name>Mallinkrodt CPAP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HFHO</intervention_name>
    <description>A device that can provide heated humidified oxygen up to 30-60 liter per minute, FiO2 (fraction of inspired oxygen) 0.21-0.95</description>
    <arm_group_label>CPAP-HFHO</arm_group_label>
    <arm_group_label>HFHO-CPAP</arm_group_label>
    <other_name>Optiflow, Airvo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All adult &gt; 18 years of age undergoes lung surgeries that required one-lung&#xD;
             ventilation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  emergency case&#xD;
&#xD;
          -  severe COPD&#xD;
&#xD;
          -  moderate baseline hypoxemia&#xD;
&#xD;
          -  pulmonary hypertension&#xD;
&#xD;
          -  difficult upper/lower airway&#xD;
&#xD;
          -  BMI &gt; 35&#xD;
&#xD;
          -  severe pneumonia&#xD;
&#xD;
          -  bronchial lavage&#xD;
&#xD;
          -  massive hemoptysis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prasert Sawasdiwipachai, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesiology, Faculty of Medicine, Siriraj Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>March 27, 2019</study_first_submitted>
  <study_first_submitted_qc>March 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 28, 2019</study_first_posted>
  <last_update_submitted>May 20, 2021</last_update_submitted>
  <last_update_submitted_qc>May 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Prasert Sawasdiwipachai</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>High flow oxygen device, HFHO, CPAP, One-lung ventilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Not yet decided</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

